Medtronic (MDT) Appoints Lidia Fonseca to its Board

Go back to Medtronic (MDT) Appoints Lidia Fonseca to its Board

Medtronic Board appoints Lidia Fonseca as a new director

June 27, 2022 7:00 AM EDT

DUBLIN, June 27, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced that its Board of Directors appointed Lidia Fonseca, Executive Vice President, Chief Digital and Technology Officer at Pfizer, to the Board as an independent director, effective June 27, 2022. Ms. Fonseca will serve on the Compensation Committee and Science and Technology Committee of the Board.

"We are thrilled to welcome Lidia to Medtronic's Board of Directors," said Geoff Martha, Medtronic chairman and chief executive officer. "She has an impressive history of developing... More